Abstract
The effects of cerivastatin on antiatherogenic properties of high-density lipoproteins were studied in patients with coronary heart disease and hyperlipidemia. Apart from hypolipidemic effects, cerivastatin changed the phospholipid composition of high-density lipoproteins and improved their cholesterol-acceptor properties. This effect was most pronounced in the serum from patients with low content of high-density lipoprotein cholesterol. These data indicate that cerivastatin modulates antiatherogenic properties of high-density lipoproteins.
Similar content being viewed by others
References
G. Assman, H. Schkiewer, G. Schmitz,et al., Clin. Chem.,29, 2026–2030 (1983).
Ph. J. Barter and K. A. Rye,Curr. Opin. Lipidol.,7, 82–87 (1996).
D. Bolin and A. Jones,J. Biol. Chem.,271, 19,152–19,158 (1996).
P. Bovet, R. Darioli, A. Essinger,et al., Atherosclerosis,80, 41–47 (1989).
M. de la Llera Moya, V. Atger, J. L. Paul,et al., Arterioscler. Thromb.,14, 1056–1065 (1994).
R. A. Demel, J. W. Jansen, P. W. Dijek,et al., Biochem. Biophys. Acta,465, 1–10 (1977).
I. Folch and M. J. Lees,J. Biol. Chem.,226, 497–509 (1957).
N. Fournier, M. de la Llera Moya,et al., J. Lipid. Res.,37, 1704–1711 (1996).
I. J. Holme,Circulation,82, 1916–1924 (1990).
F. Kunz, C. Pechlaner, R. Erhart,et al., Arterioscler. Thromb.,14, 1146–1150 (1994).
H. M. Laboda, J. M. Glick, and M. C. Phillips,Biochem. Biophys. Acta,876, 233–242 (1986).
E. A. Stein,Drugs,56, Suppl. 1, 25–31 (1998).
A. Svannborg and L. Svennercholm,Acta Med. Scand.,169, 43–45 (1961).
V. E. Vaskovsky, E. Y. Kostetsky, and J. M. Vasendin,J. Chromatogr.,114, 129–141 (1975).
C. J. Vaughan, M. B. Murphy, and B. M. Buckley,Lancet,348, 1079–1082 (1996).
Author information
Authors and Affiliations
Additional information
Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 130, No. 10, pp. 433–436, October, 2000
Rights and permissions
About this article
Cite this article
Ozerova, I.N., Jeevan, D.M., Serdyuk, A.P. et al. Cerivastatin modulates antiatherogenic properties of high-density lipoproteins in patients with coronary heart disease and hyperlipidemia. Bull Exp Biol Med 130, 983–985 (2000). https://doi.org/10.1007/BF02682045
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02682045